Emerald Mutual Fund Advisers Trust Oncocyte Corp Transaction History

Emerald Mutual Fund Advisers Trust

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Jul 28, 2020	SELL	$1.91 - $3.45 $3.89 Million - $7.02 Million	-2,035,891 Closed	0 $0
Q4 2019 Jan 29, 2020	SELL	$1.51 - $2.27 $595,376 - $895,036	-394,289 Reduced 16.22%	2,035,891 $4.58 Million
Q3 2019 Oct 31, 2019	BUY	$1.59 - $2.51 $79,500 - $125,499	50,000 Added 2.1%	2,430,180 $5.1 Million
Q2 2019 Jul 31, 2019	SELL	$2.49 - $5.45 $273,451 - $598,519	-109,820 Reduced 4.41%	2,380,180 $5.93 Million
Q1 2019 May 01, 2019	BUY	$1.47 - $5.91 $3.66 Million - $14.7 Million	2,490,000 New	2,490,000 $9.84 Million

1.16M

Ticker OCX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,609,000
Market Cap $351M
Description
OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay....

Get notified when there are updates to the investment portfolio of Emerald Mutual Fund Advisers Trust, based on Form 13F filings with the SEC.

Stay updated on Emerald Mutual Fund Advisers Trust with notifications on news.